Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At]astato-3-pyridinecarboxylate

This publication has 21 references indexed in Scilit:

• Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.
  Journal of Clinical Oncology, 1998
• Astatine-211-Labeled Biotin Conjugates Resistant to Biotinidase for Use in Pretargeted Radioimmunotherapy
  Nuclear Medicine and Biology, 1998
• Synthesis and Preliminary Biological Evaluation of (3-Iodobenzoyl)norbiotinamide and ((5-Iodo-3-pyridinyl)carbonyl)norbiotinamide: Two Radioiodinated Biotin Conjugates with Improved Stability
  Bioconjugate Chemistry, 1997
• Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (α,2n)211At reaction
  Applied Radiation and Isotopes, 1996
• Intracellular catabolism of radiolabeled anti-CD3 antibodies by leukemic T cells
  Cellular Immunology, 1991
• N-Succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodination
  Bioconjugate Chemistry, 1991
• Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.
  Proceedings of the National Academy of Sciences, 1990
• Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess
  Journal of Immunological Methods, 1984
• ChemInform Abstract: ORGANIC CHEMISTRY OF ASTATINE
  Chemischer Informationsdienst, 1981
• The preparation of astatine labelled proteins
  The International Journal of Applied Radiation and Isotopes, 1975